Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Showers, M. O.
Right arrow Articles by D'Andrea, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Showers, M. O.
Right arrow Articles by D'Andrea, A. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Activation of the erythropoietin receptor by the Friend spleen focus- forming virus gp55 glycoprotein induces constitutive protein tyrosine phosphorylation

MO Showers, JF Moreau, D Linnekin, B Druker and AD D'Andrea

Division of Hematology-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115.

The erythropoietin receptor (EPO-R) can be activated to signal cell growth by binding either EPO or gp55, the Friend spleen focus-forming virus (SFFV) glycoprotein. EPO binding induces tyrosine kinase activity and rapid tyrosine phosphorylation of several cellular substrates. To test for gp55-induced tyrosine kinase activity, we performed immunoblots on two murine cell lines that stably express EPO-R and gp55. Stimulation of the parental cell line, Ba/F3, with murine interleukin-3 (IL-3) resulted in rapid, dose-dependent tyrosine phosphorylation of a 97-Kd substrate. Stimulation with IL-3 or EPO of the Ba/F3 cells expressing the recombinant EPO-R (Ba/F3-EPO-R) resulted in tyrosine phosphorylation of the same p97 substrate. These latter cells, when transformed to growth factor-independence by the Friend gp55 glycoprotein, exhibited constitutive tyrosine phosphorylation of the 97-Kd substrate. Other growth factor-independent Ba/F3 subclones, transformed with either the oncoprotein, v-abl, or with a constitutively activated EPO-R, also had constitutive phosphorylation of a 97-Kd substrate. In CTLL-2-EPO-R cells, a T-lymphocyte line stably transfected with the EPO-R, the 97-Kd substrate was tyrosine- phosphorylated in response to IL-2 or EPO. The 97-Kd protein was constitutively phosphorylated in CTLL-2-EPO-R-gp55 cells. In conclusion, a 97-Kd protein found in two murine cell lines is tyrosine- phosphorylated in response to multiple growth factors and viral oncoproteins, and appears to be a central phosphoprotein in signal transduction.

Volume 80, Issue 12, pp. 3070-3078, 12/15/1992
Copyright © 1992 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
N. Carpino, W. E. Thierfelder, M.-s. Chang, C. Saris, S. J. Turner, S. F. Ziegler, and J. N. Ihle
Absence of an Essential Role for Thymic Stromal Lymphopoietin Receptor in Murine B-Cell Development
Mol. Cell. Biol., March 15, 2004; 24(6): 2584 - 2592.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Chen and A. J. Sytkowski
Erythropoietin Activates Two Distinct Signaling Pathways Required for the Initiation and the Elongation of c-myc
J. Biol. Chem., October 12, 2001; 276(42): 38518 - 38526.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-H. Yen, Y.-C. Yang, S. K. Ruscetti, R. A. Kirken, R. M. Dai, and C.-C. H. Li
Involvement of the Ubiquitin-Proteasome Pathway in the Degradation of Nontyrosine Kinase-Type Cytokine Receptors of IL-9, IL-2, and Erythropoietin
J. Immunol., December 1, 2000; 165(11): 6372 - 6380.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Tarr, S. S. Watowich, and G. D. Longmore
Cell Surface Organization of the Erythropoietin Receptor Complex Differs Depending on its Mode of Activation
J. Biol. Chem., April 4, 1997; 272(14): 9099 - 9107.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Feger, A. Dubart, C. Lacout, I. Dusanter-Fourt, P. Mayeux, W. Vainchenker, and D. Dumenil
Ectopic Expression of the Erythropoietin Receptor in a Murine Interleukin-6-Dependent Plasmacytoma Cell Line (TEPC-2027) Confers Proliferative Responsiveness to Erythropoietin
Blood, January 15, 1997; 89(2): 435 - 445.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. L. Barber, C. N. Corless, K. Xia, T. M. Roberts, and A. D. D'Andrea
Erythropoietin Activates Raf1 by an Shc-Independent Pathway in CTLL-EPO-R Cells
Blood, January 1, 1997; 89(1): 55 - 64.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Sakamoto, T. Kitamura, and A. Yoshimura
Mitogen-activated Protein Kinase Plays an Essential Role in the Erythropoietin-dependent Proliferation of CTLL-2 Cells
J. Biol. Chem., November 10, 2000; 275(46): 35857 - 35862.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1992 by American Society of Hematology         Online ISSN: 1528-0020